ELEVAI LABS INC.

Highlights Elevai Labs Inc.

Equities

ELAB

US28622K1043

Market Closed - Nasdaq Other stock markets 20:58:07 29/05/2024 BST			5-day change	1st Jan Change
0.665 ^USD	+3.91%		0.00%	-63.63%

05-19	Certain Common Stock of Elevai Labs, Inc. are subject to a Lock-Up Agreement Ending on 19-MAY-2024.	CI
05-02	Elevai Biosciences Inc. Highlights Preclinical Data Showing Potential of In-Licensed Asset ?EL-22? for The Treatment of Obesity	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Elevai Biosciences Inc. Highlights Preclinical Data Showing Potential of In-Licensed Asset ?EL-22? for The Treatment of Obesity	05-02	CI
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries	05-01	CI
Elevai Labs Enters into Exclusive Licensing Agreement with MOA Life Plus Co., Ltd to Develop and Commercialize Two Novel Assets for the Treatment of Obesity and Muscle Loss Prevention	05-01	CI
Elevai Labs Signs Exclusive Distribution Deal for Taiwan	04-22	MT
Elevai Labs, Inc. Enters the Taiwan Market with Signing of 5Th International Distribution Agreement in 14 Months	04-22	CI
Elevai Labs, Inc. Launches E-Commerce Portal	03-18	CI
Elevai Labs, Inc. signed a license agreement to acquire a Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology from INmune Bio, Inc..	01-15	CI
Elevai Labs, Inc. Announces New Partnership with Skin Sana Ltd	12-07	CI
Elevai Labs, Inc. Enters into Licensing Agreement with Yuva Biosciences, Inc. to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics Products	11-29	CI
Elevai Labs Closes IPO, Raises $6 Million	11-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer